TY  - BOOK
AU  - Ginsburg,Geoffrey S.
AU  - Willard,Huntington F.
TI  - Genomic and precision medicine: cardiovascular disease 
SN  - 9780128018255
AV  - RC667 .G46 2018
U1  - 616.1 23
PY  - 2018///]
CY  - London
PB  - Academic Press is an imprint of Elsevier
KW  - Cardiovascular system
KW  - Diseases
KW  - Genetic aspects
KW  - Medical genetics
KW  - Genomics
KW  - HEALTH & FITNESS / Diseases / General
KW  - bisacsh
KW  - MEDICAL / Clinical Medicine
KW  - MEDICAL / Diseases
KW  - MEDICAL / Evidence-Based Medicine
KW  - MEDICAL / Internal Medicine
KW  - fast
KW  - Cardiovascular Diseases
KW  - drug therapy
KW  - genetics
KW  - Cardiovascular Agents
KW  - therapeutic use
KW  - Precision Medicine
KW  - Electronic books
KW  - Electronic book
N1  - Title for previous editions: Genomic and personalized medicine; Revised edition of: Genomic and personalized medicine / edited by Geoffrey S. Ginsburg and Huntington F. Willard. 2nd ed. 2013; Includes bibliographical references; Family health history and health risk assessment for cardiovascular disease in health care -- Personalized lifestyle medicine -- Lipoprotein disorders -- Metabolic syndrome -- Hypertension -- Novel approaches to cardiovascular diagnostics : focus on coronary artery disease and myocardial infarction -- Hypertrophic cardiomyopathy in the era of genomic medicine -- Genomics to predict risk of coronary artery disease -- Genomics-guided antithrombotic therapy for acute coronary syndromes -- Heart failure : impact of genetics and genomics -- Arrhythmia genomics -- Genetics and genomics of peripheral arterial disease -- Genetic basis of congenital heart disease -- Perioperative genomics -- Genomics of ischemic stroke and prospects for clinical applications -- Cardiovascular pharmacogenetics
N2  - Genomic and Precision Medicine: Cardiovascular Disease, Third Edition, focuses on the applications of genome discovery on the broad spectrum of cardiovascular disorders. Each chapter is organized for the application of genomics and personalized medicine tools and technologies to a) Risk Assessment and Susceptibility, b) Diagnosis and Prognosis, c) Pharmacogenomics and Precision Therapeutics, and d) Emerging and Future Opportunities in the field
UR  - http://www.sciencedirect.com/science/book/9780128018125
ER  -